Eisai expands capacity
Eisai has announced a further hike in investment in manufacturing in order to cope with increasing overseas demand for its top-selling Aciphex and Aricept products.
Archives for November 17, 2003
UK group seeks biotech boost
Industry-backed group says UK should help support the country's biotech companies by setting up a national agency to organise clinical trials and boost companies' liquidity.
BI wins antibody contract
German biotechnology company TeGenero has signed up Boehringer Ingelheim to make clinical trials of its antibody drug in a move that reflects an emerging trend in the contract manufacturing sector.
Tough times at CyBio
Germany's CyBio, which makes laboratory instruments and equipment, has seen its revenues in the first nine months of the year fall by a third and expects to post a full-year loss.
Nicotine for the nerves
The days when cigarettes were held up in advertising as healthy products are long gone, but new research suggests there may be some substance to this - at least for some disorders affecting the brain.
Ingredient for cultural success
A new cell culture ingredient developed by Kyowa Hakko improves antibody production in mammalian cell culture by as much as 66 per cent.